Publication | Closed Access

Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaHematologyClinical TrialsMyeloid NeoplasiaHomoharringtonine-based Induction RegimensOncologyRadiation OncologyCancer ResearchPhase 3Health Sciences